Cediranib (AZD2171) in Patients With Advanced Hepatocellular Carcinoma: A Phase II North Central Cancer Treatment Group Clinical Trial : American Journal of Clinical Oncology

Secondary Logo

Journal Logo

Original Articles: Gastrointestinal

Cediranib (AZD2171) in Patients With Advanced Hepatocellular Carcinoma

A Phase II North Central Cancer Treatment Group Clinical Trial

Alberts, Steven Robert MD, MPH*; Fitch, Tom R. MD; Kim, George P. MD; Morlan, Bruce W. MS*; Dakhil, Shaker R. MD§; Gross, Howard M. MD; Nair, Suresh MD

Author Information
American Journal of Clinical Oncology 35(4):p 329-333, August 2012. | DOI: 10.1097/COC.0b013e3182118cdf

Abstract

© 2012 by Lippincott Williams & Wilkins, Inc

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid